Lenvatinib, a molecule with versatile application: from preclinical evidence to future development in anti-cancer treatment

Lenvatinib is an emerging multi-kinase inhibitor with a preferential anti-angiogenic activity, which has shown efficacy in the treatment of renal cell carcinoma, differentiated thyroid cancer and hepatocellular carcinoma. It inhibits vascular endothelial growth factor receptor family (VEGFR1–3), fib...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Manag Res
Main Authors: Capozzi, Monica, De Divitiis, Chiara, Ottaiano, Alessandro, von Arx, Claudia, Scala, Stefania, Tatangelo, Fabiana, Delrio, Paolo, Tafuto, Salvatore
Format: Artigo
Sprog:Inglês
Udgivet: Dove 2019
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6502442/
https://ncbi.nlm.nih.gov/pubmed/31118801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S188316
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker